Lipocine
LPCN
#9803
Rank
NZ$49.93 M
Marketcap
$9.34
Share price
-1.13%
Change (1 day)
97.20%
Change (1 year)

Market capitalization of Lipocine (LPCN)

Market cap: NZ$49.93 Million

As of January 2025 Lipocine has a market cap of NZ$49.93 Million. This makes Lipocine the world's 9803th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lipocine from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$49.93 M10.62%
2024NZ$45.13 M92.47%
2023NZ$23.45 M-57.71%
2022NZ$55.45 M-56.71%
2021NZ$0.12 B3.47%
2020NZ$0.12 B475.4%
2019NZ$21.51 M-48.91%
2018NZ$42.11 M-58.98%
2017NZ$0.10 B5.83%
2016NZ$97.01 M-71.85%
2015NZ$0.34 B301.28%
2014NZ$85.89 M-32.46%
2013NZ$0.12 B

End of Day market cap according to different sources

On Jan 8th, 2025 the market cap of Lipocine was reported to be:

NZ$49.93 Million
by Nasdaq info icon info icon
NZ$49.93 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$77.03 B 154,191.02%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.97 B 25,886.87%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$18.61 M-62.72%๐Ÿ‡บ๐Ÿ‡ธ USA